Bromotheophylline is the active moiety of pamabrom, a mixture of 2-amino-2-methyl-propanol and bromotheophylline. From this mixture, bromotheophylline functions as a weak diuretic that has been used along with some analgesics to relieve the symptoms of premenstrual syndrome. Bromotheophylline is categorized on the FDA as a drug substance with an inactive state since March, 1980. It is also approved by Health Canada to be used alone or in combination with [DB00316] in OTC products. The directory classifies it as a unknown/inactive API with a synthetic source/manufacturing origin. Other names for this substance include Bromotheamine and 8-Bromotheophyline. Its PubChem CID is 11808.
Bromotheophylline
| CAS No | 10381-75-6 |
|---|---|
| Molecular Formula | C7H7BrN4O2 |
| Molecular Weight | 259.06 g/mol |
| Synonyms | 8-bromo-1,3-dimethyl-7H-purine-2,6-dione |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Bromotheophylline is the active moiety of pamabrom, a mixture of 2-amino-2-methyl-propanol and bromotheophylline. From this mixture, bromotheophylline functions as a weak diuretic that has been used along with some analgesics to relieve the symptoms of premenstrual syndrome.
The listed CAS number is 10381-75-6.
The listed molecular formula is C7H7BrN4O2.
The listed molecular weight is 259.06 g/mol.
8-bromo-1,3-dimethyl-7H-purine-2,6-dione.
The source lists Bromotheamine and 8-Bromotheophyline.